B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
1:20 PM<br />
Academic <strong>Rheumatology</strong><br />
Seth M. Berney, MD; Louisana State University; Shreveport, LA<br />
1:40 PM<br />
Private Practice<br />
Joseph Flood, MD; Musculoskeletal Medical Specialists;<br />
Columbus, OH<br />
2:00 PM<br />
Government – Food and Drug Administration<br />
To be announced<br />
Session Overview:<br />
<strong>Rheumatology</strong> fellows who are completing their fellowship<br />
training <strong>of</strong>ten need direction in making career choices.<br />
Information regarding career choices may not be available to<br />
fellows within the Division <strong>of</strong> <strong>Rheumatology</strong> in which they are<br />
training. This special session presents several speakers from<br />
different career paths in rheumatology including private practice<br />
rheumatology, academic rheumatology, basic research, and<br />
government.<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• provide examples <strong>of</strong> different career choices available to<br />
young rheumatologists<br />
• discuss the pros and cons <strong>of</strong> the various career choices in<br />
rheumatology<br />
ACR Workshops<br />
1:15 - 3:15 PM<br />
Admission to each Workshop requires a separate registration<br />
and ticket. To verify which session you registered for, check to<br />
make sure the registration code on your ticket matches the code<br />
listed below in parentheses.<br />
B201<br />
Histopathology <strong>of</strong> Vasculitis (239)<br />
Speakers: Allen Burke, MD; University <strong>of</strong> Maryland Medical<br />
Center; Baltimore, MD<br />
Fabio Tavora, MD; <strong>American</strong> International Pathology<br />
Laboratories; Silver Spring, MD<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• describe histological features <strong>of</strong> normal blood vessels<br />
• distinguish pathologic reactions to vascular injury<br />
• identify histological features <strong>of</strong> major vasculitis syndromes<br />
B204<br />
Joint Injection Techniques (240) cP f PS<br />
Speakers: Atul A. Deodhar, MD; Oregon Health & Science<br />
University; Portland, OR<br />
Kenneth S. O’Rourke, MD; Wake Forest University School <strong>of</strong><br />
Medicine; Winston-Salem, NC<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• discuss indications and contraindications for joint aspirations<br />
and injections<br />
• identify and avoid common mistakes in joint injection<br />
procedures<br />
• perform common joint and s<strong>of</strong>t tissue injections on upper and<br />
lower extremities<br />
B202<br />
Musculoskeletal Imaging (241) f<br />
Speaker: William Morrison, MD; Thomas Jefferson University<br />
Hospital; Philadelphia, PA<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• describe the potential causes and exacerbating factors <strong>of</strong> the<br />
disease<br />
• discuss the appropriate use <strong>of</strong> laboratory testing and imaging<br />
modalities<br />
• design an efficacious, safe and cost-effective therapeutic<br />
strategy<br />
ACR Basic Science Symposia<br />
2:30 - 4:00 PM<br />
B402<br />
B cell Effectors and Regulators R<br />
Moderator: Nan Shen, MD; Shanghai Ren Ji Hospital; Shanghai,<br />
China<br />
2:30 PM<br />
New Insights into B cell Tolerance<br />
Eric Meffre, PhD; Yale University School <strong>of</strong> Medicine; New<br />
Haven, CT<br />
3:00 PM<br />
Ectopic Lymphoneogenesis and Effector B cells in Target Tissue<br />
in Lupus Nephritis<br />
Marcus R. Clark, MD; University <strong>of</strong> Chicago; Chicago, IL<br />
3:30 PM<br />
Regulatory B cells in Health and Disease<br />
Claudia Mauri, PhD; University <strong>College</strong> London; London,<br />
England, United Kingdom<br />
Session Overview:<br />
B cells play a critical role in the pathogenesis <strong>of</strong> many<br />
autoimmune diseases by multiple mechanisms and are also<br />
targets <strong>of</strong> emerging therapies. In addition to pathogenic<br />
effector functions, recent data has suggested anti-inflammatory<br />
regulatory roles for B cells as well. These functions can be<br />
mediated by antibodies and multiple antibody independent<br />
mechanisms including B cell cytokine secretion and direct<br />
interaction with other immune cells. This symposium will focus<br />
on new advances in our understanding <strong>of</strong> B cell regulation and<br />
effector functions with direct application to the rheumatic<br />
diseases and emerging therapies.<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• define the mechanisms by which autoreactive B cells are<br />
normally censored and how this may go awry in autoimmune<br />
disease<br />
• describe examples <strong>of</strong> B cell dysregulation in target tissue<br />
in lupus nephritis and other autoimmune diseases and the<br />
concept <strong>of</strong> ectopic lymphoneogenesis<br />
• identify the diversity <strong>of</strong> B cell subsets and function, including<br />
the ability to act in an anti-inflammatory regulatory role<br />
wednesday<br />
2010 Program Book 113